P4HB and hepatocellular carcinoma: PDIA1, in particular, is overexpressed in melanoma, lymphoma, hepatocellular carcinoma, brain, kidney, ovarian, prostate, and lung cancers6–10 and frequently associates with metastasis, invasiveness, and drug resistance11,12.